Azza Ismail

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

John Foley, Gilles Defer, Lana Zhovtis Ryerson et al. · The Lancet Neurology · 2022 · 103 citations

Relapsing-remitting Multiple Sclerosis, Clinical Neurology, Clinical Trials +8

Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis

Janine Kirby, Ke Ning, Laura Ferraiuolo et al. · Brain · 2011 · 82 citations · Full text

Neuron Survival, Amyotrophic Lateral Sclerosis, Molecular Neuroscience +13

Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of <i>C9ORF72</i>

Azza Ismail, Johnathan Cooper‐Knock, J. Robin Highley et al. · Journal of Neurology Neurosurgery & Psychiatry · 2012 · 62 citations

Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension.

Laura Edwards, Basil Sharrack, Azza Ismail et al. · PubMed · 2013 · 37 citations · Full text

Pure motor Herpes Zoster induced brachial plexopathy

Azza Ismail, Dasappaiah Ganesh Rao, Basil Sharrack · Journal of Neurology · 2009 · 26 citations

Medicine, Brachial Plexus Injury, Brachial Plexopathy +1